EUVIMEDEUVIMED entdecken
Open Access

Post-marketing surveillance of tirabrutinib for Waldenström’s macroglobulinemia/lymphoplasmacytic lymphoma in Japan

Akira Kawasaki, Toshikazu Nagano, Yudai Higuchi, Ryo Nishikawa, Koji Izutsu

Journal of Clinical and Experimental Hematopathology · 2026 · 66 (2) · 111-121

DOI: 10.3960/jslrt.25054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2026. Verfasst von Akira Kawasaki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacovigilance, Ono Pharmaceutical Co., Ltd., Osaka, Japan. Hauptthemen laut MEDLINE: Waldenstrom Macroglobulinemia, Product Surveillance, Postmarketing, Pyrimidines, Protein Kinase Inhibitors. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Waldenstrom MacroglobulinemiaProduct Surveillance, PostmarketingPyrimidinesProtein Kinase InhibitorsHumansMaleJapanAgedFemaleMiddle AgedAged, 80 and overImidazoles

Stichwörter der Autor:innen

Bruton’s tyrosine kinase inhibitorWaldenström’s macroglobulinemialymphoplasmacytic lymphomapost-marketing surveillancetirabrutinib

Substanzen

tirabrutinibPyrimidinesProtein Kinase InhibitorsImidazoles

Autor:innen und Institutionen

  • Department of Pharmacovigilance, Ono Pharmaceutical Co., Ltd., Osaka, Japan.
  • Department of Medical Affairs, Ono Pharmaceutical Co., Ltd., Osaka, Japan.
  • Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Saitama, Japan.
  • Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.

Zitieren

APA

Kawasaki, A., Nagano, T., Higuchi, Y., Nishikawa, R., & Izutsu, K. (2026). Post-marketing surveillance of tirabrutinib for Waldenström’s macroglobulinemia/lymphoplasmacytic lymphoma in Japan. Journal of Clinical and Experimental Hematopathology, 66(2), 111-121. https://doi.org/10.3960/jslrt.25054

Vancouver

Kawasaki A, Nagano T, Higuchi Y, Nishikawa R, Izutsu K. Post-marketing surveillance of tirabrutinib for Waldenström’s macroglobulinemia/lymphoplasmacytic lymphoma in Japan. Journal of Clinical and Experimental Hematopathology. 2026;66(2):111-121. doi:10.3960/jslrt.25054

BibTeX
@article{Kawasaki2026,
  author = {Kawasaki, Akira and Nagano, Toshikazu and Higuchi, Yudai and Nishikawa, Ryo and Izutsu, Koji},
  title = {Post-marketing surveillance of tirabrutinib for Waldenström’s macroglobulinemia/lymphoplasmacytic lymphoma in Japan},
  journal = {Journal of Clinical and Experimental Hematopathology},
  year = {2026},
  volume = {66},
  number = {2},
  pages = {111--121},
  doi = {10.3960/jslrt.25054}
}
Kostenlos starten →